US · MENS
Jyong Biotech Ltd. Ordinary Shares
- Sector
- Healthcare · Biotechnology
- Headquarters
- New Taipei City 221
- Website
- jyongbio.com
Price at previous close
$2.22
Market cap 166.5M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| MENS | Jyong Biotech Ltd. Ordina… | $2.22 | 166.5M | — | — | — | — | — | — | — | — | — |
| AAPG | Ascentage Pharma Group In… | $19.88 | 462.03M | — | — | — | +233% | — | — | — | — | — |
| APGE | Apogee Therapeutics, Inc. | $77.82 | 4.82B | — | — | — | — | -10.95 | 2.78 | — | -6.86 | — |
| CELC | Celcuity Inc. | $130.91 | 6.38B | — | — | — | — | -3.76 | 3.63 | — | -2.79 | — |
| CGON | CG Oncology, Inc. Common … | $60.73 | 5.36B | +3% | +145% | — | — | -27.73 | 5.93 | 1105.21 | -23.38 | 25470.00% |
| CNTA | Centessa Pharmaceuticals … | $39.81 | 6.16B | — | — | — | — | — | — | — | — | — |
| DYN | Dyne Therapeutics, Inc. | $18.56 | 3.07B | — | — | — | — | -3.68 | 1.85 | — | -1.74 | — |
| LEGN | Legend Biotech Corporatio… | $28.26 | 5.23B | — | — | — | — | — | — | — | — | — |
| RARE | Ultragenyx Pharmaceutical… | $23.26 | 2.29B | -14% | -60% | — | — | -3.95 | -28.37 | 3.37 | -5.71 | 2013.00% |
| TVTX | Travere Therapeutics, Inc… | $47.76 | 4.44B | +18% | +14,934% | — | — | -103.12 | 22.94 | 5.37 | 118.84 | 11045.00% |
| XENE | Xenon Pharmaceuticals Inc… | $54.79 | 4.33B | — | -67% | — | — | -9.75 | 5.80 | 449.63 | -8.27 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.22) − 1 = — (DCF, example).